Compugen Ltd Sustainability Reports
Compugen Ltd. is a clinical-stage therapeutic discovery and development company that utilizes an AI and machine learning-powered predictive computational platform to discover novel drug targets. The company focuses primarily on developing first-in-class immunotherapy treatments for cancer and autoimmune diseases.
Sector: Professional & technical services
Country: Israel
Exchange: Nasdaq
ISIN: IL0010852080
4 reports from 2006 to 2024